1-1 of 1
Karen Doucette, MD, FRCPC
Close
Sort by
Journal Articles

Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era

Anthea Peters, MD, MSc, FRCPC, Carolyn J Owen, MD, FRCPC, Karen Doucette, MD, FRCPC, Jutta Preiksaitis, MD, FRCPC
Journal: Blood
Blood (2011) 118 (21): 1645.
https://doi.org/10.1182/blood.V118.21.1645.1645
Published: 2011